全文获取类型
收费全文 | 490172篇 |
免费 | 65054篇 |
国内免费 | 28762篇 |
专业分类
耳鼻咽喉 | 5338篇 |
儿科学 | 7570篇 |
妇产科学 | 6531篇 |
基础医学 | 45354篇 |
口腔科学 | 11460篇 |
临床医学 | 81046篇 |
内科学 | 76778篇 |
皮肤病学 | 7469篇 |
神经病学 | 30674篇 |
特种医学 | 18000篇 |
外国民族医学 | 234篇 |
外科学 | 52005篇 |
综合类 | 75390篇 |
现状与发展 | 133篇 |
一般理论 | 31篇 |
预防医学 | 42391篇 |
眼科学 | 13366篇 |
药学 | 44276篇 |
474篇 | |
中国医学 | 26193篇 |
肿瘤学 | 39275篇 |
出版年
2024年 | 2036篇 |
2023年 | 10493篇 |
2022年 | 16440篇 |
2021年 | 22233篇 |
2020年 | 20415篇 |
2019年 | 14268篇 |
2018年 | 19525篇 |
2017年 | 19493篇 |
2016年 | 19058篇 |
2015年 | 25583篇 |
2014年 | 32331篇 |
2013年 | 32037篇 |
2012年 | 33656篇 |
2011年 | 37028篇 |
2010年 | 29480篇 |
2009年 | 27509篇 |
2008年 | 25825篇 |
2007年 | 24484篇 |
2006年 | 24616篇 |
2005年 | 22041篇 |
2004年 | 14785篇 |
2003年 | 14106篇 |
2002年 | 11600篇 |
2001年 | 10919篇 |
2000年 | 9892篇 |
1999年 | 10480篇 |
1998年 | 7559篇 |
1997年 | 7226篇 |
1996年 | 6065篇 |
1995年 | 5538篇 |
1994年 | 4324篇 |
1993年 | 2990篇 |
1992年 | 3248篇 |
1991年 | 2833篇 |
1990年 | 2364篇 |
1989年 | 2115篇 |
1988年 | 1833篇 |
1987年 | 1604篇 |
1986年 | 1340篇 |
1985年 | 988篇 |
1984年 | 625篇 |
1983年 | 570篇 |
1982年 | 367篇 |
1981年 | 364篇 |
1980年 | 234篇 |
1979年 | 217篇 |
1978年 | 192篇 |
1977年 | 167篇 |
1976年 | 117篇 |
1974年 | 112篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
目的 分析H型高血压患者的舌面诊图像颜色参数特征,探讨H型高血压患者的舌诊、面诊变化规律。方法 运用上海中医药大学自行研制的Smart TCM-1型中医舌面一体仪,采集高血压患者舌面诊图像,提取特征参数,分析健康对照组、H型高血压组与非H型高血压组患者舌面颜色参数特征。结果 ①在舌色各项参数中,H型高血压组舌尖部R值、B值、V值均显著小于健康对照组(P < 0.01);非H型高血压组舌尖部B值显著小于健康对照组(P < 0.01),S值较健康对照组显著增大(P < 0.05);H型高血压组舌尖部R、V值均明显小于非H型高血压组(P < 0.05)。在舌苔各项参数中,H型高血压组舌中H值、V值均明显小于健康对照组(P < 0.05);非H型高血压组舌中V值、舌右V值均显著小于健康对照组(P < 0.01);H型高血压组舌中H值明显小于非H型高血压组(P < 0.05),右侧舌苔S值明显大于非H型高血压组(P < 0.05)。②H型高血压组面色参数鼻G值、下颌G值、口唇R值、口唇V值均明显小于健康对照组(P < 0.05);非H型高血压组前额H值、目眶H值、脸颊H值、鼻H值、下颌H值、整体H值均明显大于健康对照组(P < 0.05);H型高血压组前额H值、目眶G值、目眶H值、脸颊H值、鼻G值、鼻H值、下颌R值、下颌G值、下颌H值、下颌V值、口唇R值、口唇G值、口唇V值、整体R值、整体G值、整体H值、整体V值均明显小于非H型高血压组(P < 0.05)。结论 H型高血压患者苔色偏黄,以舌中部为主,且舌右侧黄苔积聚较明显;H型高血压患者面色为黄中带红,口唇、下颌部更为晦暗。H型高血压患者的舌、面诊特征参数的变化,与高血压病阳亢湿盛病机相符。 相似文献
14.
15.
Xiaoqing Guo Ji-Eun Seo Xilin Li Nan Mei 《Journal of toxicology and environmental health. Part B, Critical reviews》2020,23(1):27-50
ABSTRACTGenotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment. 相似文献
16.
目的 克隆土耳其斯坦东毕吸虫磷酸丙糖异构酶的全长基因。方法 根据日本血吸虫和曼氏血吸虫磷酸丙糖异构酶基因的保守区设计引物,利用RT—PCR扩增出土耳其斯坦东毕吸虫磷酸丙糖异构酶基闪的大片段,再结合RACE技术分别得到磷酸丙糖异构酶基因的3’端和5’端,将3部分序列拼接后获得磷酸丙糖异构酶基因全长cDNA序列,并提交GenBank。结果 成功克隆了土耳其斯坦东毕吸虫磷酸丙糖异构酶基因全长cDNA序列并提交GenBank,登录号为DQ092331。结论 土耳其斯坦东毕吸虫磷酸丙糖异构酶基因全长cDNA的克隆为进一步表达及其生物学性能的分析提供了理论基础。 相似文献
17.
缺血性卒中和短暂性脑缺血发作的二级预防指南的新认识 总被引:11,自引:0,他引:11
李焰生 《国际脑血管病杂志》2006,14(5):321-324
2006年2月,美国卒中协会主办的国际卒中大会和当月出版的Stroke颁布了新的卒中和短暂性脑缺血发作(transient ischemic attack,TIA)二级预防指南[1,2]。新指南撰写委员会主席、美国哥伦比亚大学Sacco教授强调,与以前的指南[3,4]相比,新指南有了新的改进,它是一个以充分和完整证 相似文献
18.
Uwe Schneider PhD Antony Lomax Peter Pemler Jürgen Besserer Dieter Ross Norbert Lombriser Barbara Kaser-Hotz 《Strahlentherapie und Onkologie》2006,182(11):647-652
BACKGROUND AND PURPOSE: There is concern about the increase of radiation-induced malignancies with the application of modern radiation treatment techniques such as intensity-modulated radiotherapy (IMRT) and proton radiotherapy. Therefore, X-ray scatter and neutron radiation as well as the impact of the primary dose distribution on secondary cancer incidence are analyzed. MATERIAL AND METHODS: The organ equivalent dose (OED) concept with a linear-exponential and a plateau dose-response curve was applied to dose distributions of 30 patients who received radiation therapy of prostate cancer. Three-dimensional conformal radiotherapy was used in eleven patients, another eleven patients received IMRT with 6-MV photons, and eight patients were treated with spot-scanned protons. The treatment plans were recalculated with 15-MV and 18-MV photons. Secondary cancer risk was estimated based on the OED for the different treatment techniques. RESULTS: A modest increase of 15% radiation-induced cancer results from IMRT using low energies (6 MV), compared to conventional four-field planning with 15-MV photons (plateau dose-response: 1%). The probability to develop a secondary cancer increases with IMRT of higher energies by 20% and 60% for 15 MV and 18 MV, respectively (plateau dose-response: 2% and 30%). The use of spot-scanned protons can reduce secondary cancer incidence as much as 50% (independent of dose-response). CONCLUSION: By including the primary dose distribution into the analysis of radiation-induced cancer incidence, the resulting increase in risk for secondary cancer using modern treatment techniques such as IMRT is not as dramatic as expected from earlier studies. By using 6-MV photons, only a moderate risk increase is expected. Spot-scanned protons are the treatment of choice in regard to secondary cancer incidence. 相似文献
19.
20.